BridgeMD
New treatment option for Critical Care
Official title Strengthening Hope After ICU Discharge
ClinicalTrials.gov ID: NCT06569901
What this study is testing
- What it's testing
- The goal of this clinical trial is to evaluate an interventional program that aims to strengthen hope in intensive care unit (ICU) patients in the rehabilitation phase. The main questions it aims to answer are: To develop and implement a follow-up service to strengthen hope in ICU patients, and to evaluate the effect on hope in a stepped wedge randomized trial.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 85
You may be able to join if
- Patients ≥18 years
- ICU patient for \> 48 hours
- must be able to communicate verbally just after their ICU stay and be able to handle digital meetings
You likely can't join if
- Patients with severe cognitive impairment
- Do not understand and speak Norwegian
- Patients with major psychiatric challenges, suicidal attempts as a reason for ICU stay
- Age over 85 years.
The study team makes the final eligibility decision.
Where it's taking place
- Drammen, Akershus, Norway
- Oslo, Norway
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 85 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Drammen, Akershus, Norway; Oslo, Norway. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.